Učitavanje...
IMMU-35. PSYCHOSOCIAL STRESS NEGATIVELY IMPACTS IMMUNOTHERAPY IN IMMUNOCOMPETENT MODELS OF GLIOBLASTOMA
INTRODUCTION: Recent Phase III clinical trial findings indicate a failure of anti-PD-1 mAb (nivolumab) monotherapy to increase overall survival (OS) for recurrent glioblastoma (GBM) patients. Supportingly, we previously demonstrated that, while neither mono- nor dual-therapy with anti-PD-1, radiothe...
Spremljeno u:
| Izdano u: | Neuro Oncol |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216331/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.538 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|